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A method has been developed to identify the α-subunit of Shiga toxin 2 (α-Stx2) from Escherichia coli O157:H7 using matrix-
assisted laser desorption/ionization time-of-ﬂight-time-of-ﬂight tandem mass spectrometry (MALDI-TOF-TOF-MS/MS) and
top-down proteomics using web-based software developed in-house. Expression of Stx2 was induced by culturing E. coli O157:H7
on solid agar supplemented with an antibiotic that elicits the bacterial SOS-response. Bacterial cell lysates were incubated in the
presence of furin, a human enzyme, that cleaves α-Stx2 into A1 (∼28kDa) and A2 (∼5kDa) protein fragments. A subsequent
disulﬁde reduction step unlinked A1 from A2. MALDI-TOF-MS of the furin-digested/disulﬁde-reduced sample showed a peak at
mass-to-charge (m/z) 5286 that corresponded to the A2 fragment. No peak was observed that corresponded to the A1 fragment
although its presence was conﬁrmed by bottom-up proteomics. The peak at m/z 5286 was deﬁnitively identiﬁed by MALDI-TOF-
TOF-MS/MS and top-down proteomics as the A2 fragment of α-Stx2.
1.Introduction
Protein toxins are a major etiological agent of severe
illness caused by foodborne bacterial pathogens [1]. The
importance of bacterial protein toxins has resulted in the
development of techniques to identify them as well as other
virulence factors a microorganism may harbor. For example,
polymerase chain reaction (PCR) may be used to amplify
short segments of toxin genes demonstrating the presence of
suchgenes and the potential of the microorganism to express
the toxin [2–4]. Alternatively, an enzyme immunoassay
(EIA) may be used to indirectly detect the actual expression
of a protein toxin by a microorganism [2, 5, 6]. Another
approach for toxin detection is to measure its toxic eﬀects on
mammalian cells in vitro [7]. Because of its speed, sensitivity,
and high speciﬁcity, mass spectrometry has been used to
unambiguously detect, characterize, and identify chemical
compounds including protein toxins [8].
One of the most important bacterial protein toxins is
Shiga toxin (also referred to as Shiga-like toxin or verotoxin)
[9–11].Shigatoxin(Stx)isanAB5 toxinpossessinganα-and
β-subunit. Five identical β-subunits form a noncovalently
assembled donut-shaped complex. A single α-subunit is
positioned primarily on one side of the β-complex (A1)
and the central core formed from the β-pentamer (A2). A
highly accessible 20-residue loop in the polypeptide chain
of the α-subunit facilitates cleavage of the α-subunit into its
A1 and A2 fragments. The base of the 20-residue loop is
linked by a disulﬁde bond. When released by bacterial cell
lysis in the human gut, the holotoxin attaches itself to the
glycosphingolipid globotriaosylceramide (Gb3 also referred
to as CD77) receptors on the surface of intestinal endothelial
cells and/or other cells in the human body that have the
same surface receptor, for example, kidney cells [12, 13].
Attachment of the β-complex to Gb3 occurs on the side
opposite to that of the α-subunit [9].
The toxin is introduced into eukaryotic cells by endo-
cytosis. Early endosomes are transported, in a retrograde
fashion, to the Golgi apparatus and eventually to the
endoplasmic reticulum (ER) [9]. At some point in the early2 Journal of Biomedicine and Biotechnology
endosome, the α-subunit is proteolytically cleaved by furin,
a membrane protein. However, even after this cleavage, the
A1 and A2 fragments are still bound by a disulﬁde bond.
This disulﬁde bond is subsequently reduced in the lumen
of the ER, and the catalytically active A1 fragment is then
translocated to the cytosol where it disrupts eukaryotic
ribosomal protein synthesis eventually resulting in cell death
[9, 14].
Previous approaches that use matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry
(MALDI-TOF-MS) for bacterial identiﬁcation typically
attempt to detect as many bacterial proteins as possible
in order to obtain as unique an MS “ﬁngerprint” as
possible [15–29]. Alternatively, matrix-assisted laser
desorption/ionization time-of-ﬂight time-of-ﬂight tandem
mass spectrometry (MALDI-TOF-TOF-MS/MS) has been
used to fragment intact bacterial proteins by MS/MS and
identify them (and their source microorganism) by top-
down proteomic analysis [30–33]. We have recently reported
using MALDI-TOF-TOF-MS/MS to ionize, isolate, and
fragment intact protein ions from bacterial cell lysates [31,
32]. Using software developed in-house, the mass-to-charge
(m/z) of MS/MS fragment ions are compared to a database
of in silico fragment ion m/z derived from bacterial protein
sequenceshavingthesamemolecularweight(MW)asthatof
the protein ion. A simple peak matching algorithm [31, 32]
and a P-value scoring algorithm (developed by others [30])
were used to independently score/rank identiﬁcations. This
approach to bacterial protein identiﬁcation is particularly
attractive as sample preparation is simple and does not
require pre-enrichment or chromatographic separation
of proteins. MALDI-TOF-TOF-MS/MS analysis is quickly
accomplished after an equally rapid MALDI-TOF-MS
analysis. Both MALDI-TOF-MS and MALDI-TOF-TOF-
MS/MS approaches are accomplished by culturing bacterial
cellsonmediathatfacilitatesbacterialgrowth.However,such
growth conditions do not necessarily result in expression of
important bacterial virulence factors which could be used to
characterize the pathogenicity of the microorganism.
In the current study, we induce expression of a speciﬁc
bacterial virulence factor most often linked to cases of severe
foodborne illness [12, 13]. We have applied our top-down
MALDI-TOF-TOF-MS/MStechniquetotheidentiﬁcationof
the α-subunit of Shiga toxin 2 (α-Stx2) from a genomically
sequenced strain of E. coli O157:H7 [34]. Expression of α-
Stx2 was induced by culturing on a conventional solid agar
supplemented with an antibiotic that is a powerful inducer
of the bacterial SOS-response [35–38].
2.MaterialandMethods
2.1. Induction of Stx2 from E. coli O157:H7. The E. coli
O157:H7 strain used in the current study is the genomically
sequenced strain EDL933 (ATCC # 43895) which possesses
thegeneforShigatoxin2(stx2)aswellasothervirulencefac-
tors [34]. Expression of Stx2 in E. coli O157:H7 was induced
by overnight culturing at 37◦C on Luria-Bertani agar (LBA)
plates supplemented with 20ng/mL of ciproﬂoxacin (CP), a
ﬂuoroquinolone antibiotic. The use of ﬂuoroquinolones to
induce expression of Stx has been described previously [35–
38].
2.2. In Vitro Furin-Induced Cleavage of α-Stx2. OneμLo f
bacterial cells was harvested with a sterile 1μLt r a n s f e rl o o p
and transferred to a sterile 2mL microcentrifuge tube con-
taining 300μL of a sterile solution of 3mM molecular grade
CaCl2 (Sigma-Aldrich, St. Louis, MO) in HPLC grade water
(Burdick and Jackson) and approximately 100mg of 0.1mm
zirconia-silica beads (BioSpec Products, Bartlesville, OK).
The tubes were bead-beat for 60 seconds on a reciprocating
shaker (Mini-Beadbeater; Biospec Products, Bartlesville,
OK) after which they were centrifuged at 14,000rpm for 2
minutes.
One μL of furin enzyme (2000units/mL, New England
BioLabs, Ipswich, MA) was added to 30μLo fb a c t e r i a lc e l l
supernatant in a sterile 500μL thin-walled PCR tube and
incubated at 37◦C for 10, 30, or 60 minutes. The furin
recognition site (RXXR) for cleavage of the α-Stx2 is located
in a highly accessible loop of the polypeptide chain between
two cysteine residues (Cys241 and Cys260)w h i c hf o r ma n
intramolecular disulﬁde bond (Figure 1)[ 14, 39]. After furin
digestion,1.5μLof1Mmoleculargradedithiothreitol(DTT,
Sigma-Aldrich, St. Louis, MO) was added to the reaction
mixture followed by incubation at 70◦Cf o r1 0m i n u t e s
in order to reduce the intramolecular disulﬁde bond and
unlinkthetwofragments(A1andA2)oftheα-subunit.DTT
appeared to inhibit furin enzyme activity; in consequence,
it was added after completion of the furin digestion step. A
negative control in the absence of furin and DTT was also
p e r f o r m e d .T h er e a c t i o np r o d u c t sw e r ea n a l y z e db yM Sa n d
MS/MS.
2.3. One-Dimensional Polyacrylamide Gel Electrophoresis (1D
PAGE). Approximately, 2μL of bacterial cells were harvested
fromaCP-supplementedLBAsolidagarplateafterovernight
growthandtransferredtoamicrocentrifugetubewith300μL
of extraction solution and processed as previously described.
Foronesample,4μLoffurinw er eaddedt o30μLofbact erial
cell lysate and incubated at 37◦Cf o r3h o u r sf o l l o w e db ya
disulﬁde reduction step as previously described. A 19.5μL
aliquot of this sample was combined with 6.5μLo fN u P A G E
L D SS a m p l eB u ﬀer (Invitrogen, Carlsbad, CA). For another
sample, 16.9μL of bacterial cell lysate was added to 6.5μL
L D Ss a m p l eb u ﬀer and 2.6μL NuPAGE reducing agent
(NuPAGE, Invitrogen, Carlsbad, CA) and incubated for 10
minutes at 70◦C. A total of 25μL of each sample was applied
toseparatelanesofa1.0mmNuPAGENovex4–12%Bis-Tris
mini-gel (NuPAGE, Invitrogen, Carlsbad, CA). The upper
(cathode) buﬀer chamber consisted of 200mL of MES SDS
running buﬀer containing 500μL of NuPAGE antioxidant
reagent (Invitrogen, Carlsbad, CA) to maintain proteins in
a reduced state during electrophoresis. A constant-voltage
(200V) was applied for 40 minutes. The gel was stained
with a Coomasie staining solution (SimplyBlue-SafeStain,
Invitrogen, Carlsbad, CA) using the supplier’s microwave
procedure and imaged (Supplementary Materials). Relevant
gel bands were excised and in-gel digested with porcineJournal of Biomedicine and Biotechnology 3
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Figure 1: Sequence of α-Stx2 from E. coli O157:H7 (EDL933). A 22-residue signal peptide (in bold) is removed in the mature protein, and
cysteines involved in an intramolecular disulﬁde bond (S···S) are boxed. Potential furin cleavage recognition sites (RXXR) are boxed. An
asterisk (∗) marks the observed furin cleavage site. In eukaryotic cells, after disulﬁde reduction, the catalytically active αA1-Stx2 fragment is
translocated to the cytosol and the αA2-Stx2 fragment remains associated with the β-pentamer.
trypsin (Promega, Madison, WI) using standard protocols
(DigestPro, Intavis, Langenfeld, Germany).
2.4. Bottom-Up Proteomic Analysis. Twenty μLo fe a c h
digest were separated by nano-HPLC (LC Packings/Dionex,
Sunnyvale, CA) and analyzed by MS and MS/MS using a
Q-Star-Pulsar I (Applied Biosytems, Foster City, CA) [40].
Peptides (and their corresponding proteins) were identiﬁed
by analysis of MS and MS/MS data using MASCOT [41]
using NCBInr and SwissProt databases. Taxonomy was
left unrestricted so as to search against both bacterial
and bacteriophage databases. The top protein/organism
identiﬁcations were Escherichia coli and/or enterobacteria
phage BP-933W which is present in the E. coli O157:H7
(strain EDL933). Peptide and protein identiﬁcations are
provided in Supplementary Materials available online at doi:
10.1155/2010/123460.
2.5. MALDI-TOF-MS and MS/MS. Mass spectrometry and
top-down analysis has been described in detail [31, 32].
Brieﬂy, 0.5μL of sample was spotted onto a 384-well
stainless steel target and allowed to dry at room temper-
ature. The dried sample spot was overlayed with 0.5μL
aliquot of saturated MALDI matrix solution of α-cyano-
4-hydroxycinnamic acid (HCCA, Fluka Analytical) or 3,5-
dimethoxy-4-hydroxycinnamic acid (sinapinic acid, Fluka
Analytical) in 67% HPLC grade water, 33% HPLC grade
acetonitrile, and 0.2% triﬂuoroacetic acid. MS and MS/MS
analysis was performed using a 4800 Plus MALDI-TOF/TOF
tandem mass spectrometer (Applied Biosystems, Foster City,
CA) equipped with a 200Hz YAG laser (λ = 355nm).
MS analysis was performed in linear positive ion mode
using default instrument settings. Ions were accelerated
from the ﬁrst source at 20kV. The linear mode was exter-
nally calibrated with a mixture of cytochrome C (MW =
12,361.088Da), lysozyme (MW = 14,306.200Da), and myo-
globin (MW = 16,952.551Da). MS spectra were acquired
using 1000 laser shots. MS/MS analysis was performed
in positive ion reﬂectron mode. The reﬂectron mode was
externally calibrated using the fragment ions at mass-to-
charge (m/z) of 175.119, 684.346, 813.389, 1,056.475, and
1,441.634 from postsource dissociation (PSD) of the singly
charged (protonated) precursor ion of glu-ﬁbrino-peptide B
(Sigma-Aldrich, MW = 1,570.60Da).
For intact protein ion fragmentation, the instrument was
operated using the default settings of the operating mode:
MS/MS 1kV positive sensitivity. The metastable suppressor
was enabled and the timed ion selector (TIS) was operated
at a resolution of ±100Da. In order to maximize protein ion
fragmentation eﬃciency, a higher than normal laser ﬂuence
was utilized [30–32]. Positive ions were accelerated from the
source at 8.0kV, decelerated to 1kV in the collision cell, and
reaccelerated to 15kV in the second source. However, no
target gas was introduced into the collision cell. MS/MS data
were acquired using 10,000 laser shots.
Raw MS and MS/MS data were processed using the
commercial software provided with the instrument (Data4 Journal of Biomedicine and Biotechnology
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Figure 2:MALDI-TOF-MSofbacterialcell lysatesatdiﬀerent furindigestion times.Bottompanel isaplotofpeak height of m/z 5286 versus
furin digestion time. Data points are ﬁtted to a simple exponential function.
Explorer v4.9, Applied Biosystems, Foster City, CA). MS
spectra were processed with a noise ﬁlter (correlation factor
= 0.7) and then centroided. MS/MS spectra were processed,
ﬁrst with an advanced baseline correction (peak width = 32,
ﬂexibility = 0.5, degree = 0.1), followed by a noise removal
(standard deviation = 2), followed by a Gaussian smooth
(ﬁlter width = 31 points), and then centroided. Processed
MS and MS/MS data were exported from the instrument
software as an ASCII ﬁle (m/z versus absolute intensity) and
then uploaded to their respective databases in the USDA
software.
2.6. Top-Down Proteomic Analysis. The USDA software and
its use for top-down proteomic analysis has been described
in detail [32]. Brieﬂy, the program rapidly compares the
m/z of MS/MS fragments to the m/z of in silico fragment
ions derived from bacterial protein sequences that have
the same molecular weight (MW) as that of the protein
biomarker ion being analyzed. The program was written
using a Java runtime environment with MySQL database
management and a Tomcat/Apache web interface. Bacterial
protein sequences were retrieved using the TagIdent software
tool from ExPASy website (http://www.expasy.org/)f r o mJournal of Biomedicine and Biotechnology 5
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Figure 3: MS/MS of the precursor ion at m/z 5286 in Figure 2. Fragment ions marked with a solid circle were also observed in the MS/MS
spectrum of the precursor ion at m/z 5250 (Figure S1). Fragment ions matched to in silico fragments ions of αA2-Stx2 are identiﬁed by their
ion type/number and the two amino acid residues adjacent to the site of polypeptide cleavage. Sequence of αA2-Stx2. Asterisk indicates site
of gas phase fragmentation with corresponding ion type/number. D, E, and P residues are highlighted in red.
UniProtKB/Swiss-Prot databases (versions 18-May-2010 or
15-June-2010). The downloaded multisequence FASTA ﬁles
were processed using a beta-version GPMAW (version 8.01
a5) and the resulting ﬁles were uploaded to the in silico
database of the USDA software. The USDA software uses
a simple peak matching algorithm [32]a n daP-value
algorithm (developed by Demirev and coworkers [30]) to
independently score/rank MS/MS-to-in silico comparisons.
3. Results andDiscussion
Figure 1 shows the full protein sequence of the α-Stx2 from
E. coli O157:H7 strain EDL933 (ave. MW = 35,710.5Da).
However, this protein toxin has a 22-residue N-terminal
signalpeptideaswellasadisulﬁdebridgebetweenCys263 and
Cys282 (Cys241 and Cys260 in the posttranslationally modiﬁed
protein). The posttranslationally modiﬁed MW of α-Stx2
is thus 33,192.3Da. Furin cleavage of the α-Stx2 (followed
by disulﬁde reduction) should result in formation of two
fragments:A1(αA1-Stx2)withanaverageMWof27,927.5Da
and A2 (αA2-Stx2) with an average MW of 5284.9Da.
Figure 2 shows MALDI-TOF-MS spectra of furin-digested
b a c t e r i a lc e l ll y s a t eo fE. coli O157:H7 cultured on solid
agar supplemented with 20ng/mL of ciproﬂoxacin. Furin
digestion times are indicated for each MALDI-TOF-MS
spectrum. Each spectrum includes an insert of the expanded
display range at ∼m/z 5300. The most prominent peak in the
spectra in Figure 2 is at ∼m/z 7814. This protein ion peak
corresponds to the β-subunit of Stx2 (β-Stx2) as identiﬁed
by top-down proteomic analysis [42]. As each β-subunit
monomerispartofapentamercomplexinsolution towhich
a single α-subunit is associated, it is to be expected that the
β-subunit is the most prominent protein ion given the 1:5
stoichiometric ratio of α:β subunits for the AB5 holotoxin
[9]. A peak at m/z ∼ 5286, corresponding to the αA2-Stx2,
is not observed when furin digestion is not included in the
sample preparation (Figure 2(a)). A peak observed at m/z
5251 is approximately one-half the m/z of a peak at m/z
10497. MS/MS of the peaks at m/z 5251 and m/z 10497 was
performed which showed several prominent fragment ions
that were common to both MS/MS spectra suggesting that
these ions are the +2 and +1 charge state of the same protein,
respectively (Supplementary Materials). Unfortunately, we
were unable to identify this protein by either top-down or
bottom-up proteomic analysis. The data acquisition upper
mass range was extended up to m/z 30,000; however, no
peaks were observed that corresponded to αA1-Stx2.
Furin digestion of the bacterial cell lysate for 10 minutes
resulted in the MALDI-TOF-MS spectrum (Figure 2(b))
which shows the sudden appearance of what is presumably
a singly charged ion at m/z 5286. The neighboring doubly
chargedionatm/z ∼ 5250isalsopresent.Asthefurindiges-
tion time increases from 10 to 30 to 60 minutes, the absolute
intensity of the peak at m/z 5286 increases proportionally
with a concomitant increase in its signal-to-noise (S/N). A
plot of the absolute intensity of the peak at m/z 5286 as
a function of furin digestion time is shown in Figure 2(e).
Data points were ﬁtted to a simple exponential. The strong
correlation between peak intensity and furin digestion time
suggests that the peak at m/z 5286 is the αA2-Stx2. In order
to deﬁnitively identify it, this peak was subjected to MALDI-
TOF-TOF-MS/MS and top-down analysis.6 Journal of Biomedicine and Biotechnology
Figure 3 shows the MS/MS spectrum of the peak at
m/z 5286. Prominent MS/MS fragment ions are identiﬁed
by their m/z. Fragment ions with a corresponding in silico
fragment ion match to the top-ranked protein identiﬁcation
(αA2-Stx2 in Table 1)a r ei d e n t i ﬁ e db yt h e i rm/z, the in
silico fragment ion type/number and the two amino acid
residues immediately adjacent to the sequence cleavage site
that resulted in the fragment ion. Some of the more intense
MS/MS fragment ions are matched to in silico fragment
ions adjacent to aspartic acid (D), glutamic acid (E), and
proline (P) residues. Fragmentation of the polypeptide chain
of singly charged (protonated) protein ions at D, E, or
P residues has been noted previously [30–33, 43]. These
residues facilitate fragmentation by either transferring a
protonfromtheirside-chaintothepolypeptidebackbone(as
in the case of D and E residues) or by creating an internal
energy bottleneck in the molecule (as in the case of P residue
that results in a 90◦ turn in the polypeptide backbone). As
shown in Figure 3, a number of MS/MS fragment ions were
also matched to in silico fragment ions that are adjacent
to non-D/E/P-residues. The relatively small size of this
protein ion results in fragmentation throughout the entire
polypeptide as shown in the insert of Figure 3 (not just at
D, E, or P residues). The fragmentation eﬃciency of smaller
protein ions is higher compared to larger protein ions due
to the fact that larger protein ions have a greater number of
vibrational degrees-of-freedom to redistribute their internal
energy. In the current experiment, energy is deposited into
the protein during laser desorption/ionization. The energy
is then rapidly redistributed and the metastable protein
ion fragments sometime after exiting the source, that is,
postsource dissociation or PSD. As the size of the protein
ion being analyzed increases, fragmentation is more likely to
occur at dissociation channels that require the least amount
of energy, that is, cleavage at D, E, or P residues.
Six prominent fragment ion peaks in Figure 3 (marked
by solid circle) had no corresponding in silico match to
the αA2-Stx2 sequence but were found to be present in the
MS/MS spectrum of the doubly charged ion at m/z ∼ 5250
(Figure S1, Supplementary Materials). Even at the highest
TIS resolution (±50Da), it was not possible to fully resolve
and thus mass isolate the ion at m/z 5286 from the ion
at m/z ∼ 5251. In consequence, some fragment ions from
the precursor ion at m/z 5251 are present in the MS/MS
spectrum for m/z 5286.
Table 1 shows the top ranked identiﬁcations of the pro-
tein ion at m/z 5286 analyzed by MALDI-TOF-TOF-MS/MS
and top down proteomics. MS/MS fragment ions were
analyzed using a non-residue-speciﬁc in silico comparison
to 3833 bacterial protein sequences having the same MW
as that of the biomarker (within ±10Da). The top-ranked
identiﬁcation of both the USDA score and the P-value is
the A2 fragment of the furin-cleaved α-Stx2. Nearly all
of the more prominent MS/MS fragment ions shown in
Figure 3 were matched to in silico fragment ions of αA2-
Stx2. The theoretical and observed MW also corresponded
excellently. As can be seen from Table 1, the sequence of αA2-
Stx2 is common to several serotypes and strains of E. coli
(including O157:H7) as well as Acinetobacter haemolyticus
and many bacteriophages. Bacteriophages play a critical
rˆ ole in facilitating horizontal gene transfer across bacterial
genera, species, subspecies, subtypes, and strains [44, 45].
The fact that A. haemolyticus has recently been reported
to carry the Stx2 gene [46] suggests that the spread of Stx
genes(andothervirulencefactors)acrossbacteria,facilitated
by bacteriophages, may be increasing. The second ranked
identiﬁcations in Table 1 have P-values that are 10 orders-
of-magnitude less signiﬁcant compared to that of the top-
ranked identiﬁcation. The % of matched MS/MS fragment
ions (USDA score) is nearly double that for the top ranked
identiﬁcation compared to second-ranked identiﬁcations.
The USDA algorithm is approximately 8 times faster (84
seconds) to score than the more mathematically complex P-
value algorithm (654 seconds) due to the number of MS/MS
fragment ions being compared (118) and the number of
bacterial protein sequences being compared against (3833).
The A1 fragment of the furin-cleaved α-Stx2 was not
observed by MALDI-TOF-MS. In consequence, we analyzed,
by 1-D PAGE, the proteins from CP-supplemented and CP-
supplemented/furin-digested bacterial cell lysates (Figure S3,
Supplementary Materials). In the bacterial cell lysate of the
CP-supplemented sample, we observe a band at ∼33kDa
which is absent from the CP-supplemented/furin-digested
sample. This gel band was excised, in-gel digested, and
analyzed by bottom-up proteomics. The band corresponded
to α-Stx2 and, as shown in Figure 4, the sequence coverage
included partial sequences A1 and A2 and no sequence
coverage of the signal peptide as one would expect for the
mature protein. The 33kDa also corresponds closely to the
theoretical MW of 33,192.3Da. In the bacterial cell lysate
of the CP-supplemented/furin-digested sample, we observe
bands at ∼28kDa and ∼5-6kDa which are absent from the
CP-supplemented sample. These bands were also analyzed
by bottom-up proteomics and identiﬁed as α-Stx2 with
partialsequencecoveragethatwasconsistentwiththeA1and
A2 fragments, respectively (Figure 4). These results strongly
suggest that both A1 and A2 fragments of α-Stx2 are present
in the CP-supplemented/furin-digested sample, but only the
A2 fragment is successfully ionized by MALDI.
There are a number of possible explanations that may
account for the failure to ionize the A1 fragment of α-
Stx2 by MALDI. First, MALDI favors ionization of lower
MW proteins and peptides. Second, the primary sequence,
secondary, or tertiary structure of A1 may not eﬃciently
ionize (protonate) compared with other analytes present
in the sample. We do not observe any evidence for furin
cleavage at other potential recognition sites (RXXR) in the
primary structure of A1. It is possible these other sites are
not readily accessible to furin and may suggest a compact
tertiary structure for αA1-Stx2 that thwarts ionization. Third,
A1isthecatalyticallyactivefragmentthatbindstoeukaryotic
ribosomal RNA and disrupts protein synthesis. It has been
previously reported that αA1-Stx2 also binds to prokaryotic
RNA or DNA [47]. It is possible that the diﬃculty in
detecting A1 could be due to its being bound to bacterial
R N Ao rD N Aw h o s em a s se x c e e d st h eu p p e rm a s sd e t e c t i o n
limit of our instrument. Preliminary experiments were
conducted to process samples with RNAase and DNAaseJournal of Biomedicine and Biotechnology 7
Table 1: The top identiﬁcations of the protein biomarker ion at m/z 5286 analyzed by MALDI-TOF-TOF-MS/MS (Figure 3) and top-down
proteomics.
Rank In silico ID Identiﬁer Sample name Protein USDA
score P-value
86486 >tr|Q7DI68|Q7DI68 ECO57 Escherichia coli
O157:H7
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86481 >tr|C6UP09|C6UP09 ECO5T
Escherichia coli
O157:H7 (strain
TW14359/EHEC)
Shiga toxin II α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86490 >tr|Q7B5L0|Q7B5L0 ECOLX Escherichia coli
O157:Hneg
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86517 >tr|Q6YII8|Q6YII8 ECOLX Escherichia coli
O157:Hneg
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86463 >tr|B3VKH7|B3VKH7 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86464 >tr|C5J4Y3|C5J4Y3 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
1 86467 >tr|Q5WPW9|Q5WPW9 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86468 >tr|Q8KU16|Q8KU16 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86469 >tr|Q8XBV2|Q8XBV2 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86473 >tr|B3VKI5|B3VKI5 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86474 >tr|B2MW60|B2MW60 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86478 >tr|C7FPV8|C7FPV8 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86480 >tr|Q47636|Q47636 ECOLX Escherichia coli
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86472 >tr|Q1ELX7|Q1ELX7 ECOLX Escherichia coli
O111:NM
Shiga toxin II α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86483 >tr|Q2L9B4|Q2L9B4 ACIHA Acinetobacter
haemolyticus
Shiga toxin II α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
50965 >sp|P09385|STXA BP933 Enterobacteria
phage 933W
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86458 >sp|P09385|STXA BP933 Enterobacteria
phage 933W
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86459 >tr|Q776E1|Q776E1 9CAUD Stx2 converting
phage II
Shiga toxin 2 α-subunit
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−138 Journal of Biomedicine and Biotechnology
Table 1: Continued.
Rank In silico ID Identiﬁer Sample name Protein USDA
score P-value
86491 >tr|Q776Q3|Q776Q3 BPVT2 Enterobacteria
phage VT2-Sa
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86494 >tr|Q77CH9|Q77CH9 9VIRU Enterobacteria
phage LC159
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86499 >tr|Q77CH6|Q77CH6 9VIRU Enterobacteria
phage SC370
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86503 >tr|Q6DWK9|Q6DWK9 9VIRU Enterobacteria
phage A397
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86518 >tr|Q08JA4|Q08JA4 9CAUD Stx2-converting
phage 86
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86519 >tr|B0FEE0|B0FEE0 9CAUD Enterobacteria
phage Min27
Shiga-like toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
86520 >tr|Q776G1|Q776G1 9CAUD Stx2 converting
phage I
Shiga toxin 2 α-sub.
(furin-cleaved sequence)
MW = 5284.9
42.37 2.2E−13
2 66935 >tr|A1AXT4|A1AXT4 RUTMC
Ruthia magniﬁca
sub. Calyptogena
magniﬁca
50S ribosomal protein L34 PTM-Met
MW = 5280.3 24.58
79662 >tr|B1C7H9|B1C7H9 9FIRM
Anaerofustis
stercorihominis
DSM 17244
Putative uncharacterized protein
MW = 5283.49 1.2E−3
2 68014 >tr|A7FRA0|A7FRA0 CLOB1
Clostridium
botulinum (strain
ATCC
19397/Type A)
Bacteriophage prototoxin,
streptolysin S family PTM-Met
MW = 5284.93
24.58
3 66935 >tr|A1AXT4|A1AXT4 RUTMC
Ruthia magniﬁca
sub. Calyptogena
magniﬁca
50S ribosomal protein L34 PTM-Met
MW = 5280.3 1.4E−3
2 68024 >tr|A7G124|A7G124 CLOBH
Clostridium
botulinum (strain
Hall/ATCC
3502/NCTC
13319/Type A)
Bacteriophage prototoxin,
streptolysin S family PTM-Met
MW = 5284.93
24.58
4 76887 >tr|Q73I98|Q73I98 WOLPM Wolbachia
pipientis wMel
Putative uncharacterized protein
PTM-Met
MW = 5285.2
3.9E−3
2 68030 >tr|A7GAP1|A7GAP1 CLOBL
Clostridium
botulinum (strain
Langeland/NCTC
10281/Type F)
Bacteriophage prototoxin,
streptolysin S family PTM-Met
MW = 5284.93
24.58
5 67756 >tr|A5ZL78|A5ZL78 9BACE Bacteroides caccae
ATCC 43185
Putative uncharacterized protein
PTM-Met
MW = 5278.67
5.2E−3
2 69116 >tr|B1IEJ6|B1IEJ6 CLOBK
Clostridium
botulinum (strain
Okra/Type B1)
Bacteriophage prototoxin,
streptolysin S family PTM-Met
MW = 5284.93
24.58
5 75125 >tr|D1P267|D1P267 9ENTR
Providencia
rustigianii DSM
4541
Putative uncharacterized protein
PTM-Met
MW = 5287.4
5.2E−3
Comparison parameters: minimum intensity threshold: 2; fragment ion tolerance in m/z: ±1.5; protein mass tolerance: ±10Da; number of MS/MS above
minimum intensity threshold: 118; non-residue-speciﬁc in silico comparison; 3833 bacterial protein sequences compared. Algorithm computation times:
USDA score 84 seconds, P-value 654 seconds.Journal of Biomedicine and Biotechnology 9
REFTIDFSTQQSYVSSLNSIRTEISTPLEHISQGTTSV
SVI NHTPPGSYFAVDI RGLDVYQARFDHLRLIIEQNNLYVAGFVNTATNTFYRFS DFTHI
SVPGVTTVSM TTDSSYTTLQRVAALERSGM QI SRH SLVSSYLALM EFSGN TM TRDAS
RAVLRFVTVTAEALRFRQIQREFRQALSETAPVYTMTPGDVDLTLNWGRIS NVLP E Y
RGEDGVRVGRIS FNNIS AILGTVAVILNCHHQGA RS VR AVNEESQPECQITGDRPVIK
INNTLWES NTAAAFLNRKS QFLYTTGK
REFTIDFSTQQSYVSSLNSIRTEISTPLEHISQGTTSV
SVI NHTPPGSYFAVDI RGLDVYQARFDHLRLIIEQNNLYVAGFVNTATNTFYRFSDFTHI
SVPGVTTVSM TTDSSYTTLQRVAALERSGM QI SRHSLVSSYLALMEFSGNTMTRDAS
RAVLRFVTVTAEALRFRQIQREFRQALSETAPVYTMTPGDVDLTLNWGRIS NVLP E Y
RGEDGVRVGRISFNNISAILGTVAVILNCHHQGARSVR AVNEESQPECQITGDRPVIK
INNTLWES NTAAAFLNRKS QFLYTTGK
REFTIDFSTQQSYVSSLNSIRTEISTPLEHISQGTTSV
SVINHTPPGSYFAVDIRGLDVYQARFDHLRLIIEQNNLYVAGFVNTATNTFYRFSDFTHI
SVPGVTTVSM TTDSSYTTLQRVAALERSGM QI SRH SLVSSYLALM EFSGN TM TRDAS
RAVLRFVTVTAEALRFRQIQREFRQALSETAPVYTMTPGDVDLTLNWGRISNVLPEY
RGEDGVRVGRISFNNISAILGTVAVILNCHHQGARSVR AVNEESQPECQITGDRPVIK
INNTLWESNTAAAFLNRKSQFLYTTGK
∗
∗
∗
MKCILFKWVLCLLLGFSSVSYS
MKCILFKWVLCLLLGFSSVSYS
MKCILFKWVLCLLLGFSSVSYS
Gel band at ∼33kDa (lane 3, gel band #1)
Gel band at ∼28kDa (lane 4, gel band #3)
Gel band at ∼5-6kDa (lane 4, gel band #9)
Figure 4: Bottom-up proteomic sequence coverage of α-Stx2 (in red) from select gel bands (Figure S3, Supplementary Materials). A 22-
residue signal peptide (in bold) is removed in the mature protein. Recognition sites for potential furin cleavage (RXXR) are boxed. An
asterisk (∗) marks the only observed furin cleavage site.
on the assumption that cleaving the RNA or DNA into
smaller units might facilitate ionization of the A1 fragment.
However, the A1 fragment was still not detected by MALDI-
TOF-MS.
4. Conclusions
We have detected and identiﬁed the antibiotic-induced,
furin-cleaved α-Stx2 from E. coli O157:H7 using MALDI-
TOF-TOF-MS/MS and top-down proteomics. Bacterial cell
lysates from growth on conventional solid agar supple-
mented with ciproﬂoxacin strongly induced expression of
Stx2 allowing ionization by MALDI. The human enzyme
furin was used to cleave α-Stx2 at the highly accessible
polypeptide loop that joins the A1 and A2 fragments of α-
Stx2. A further disulﬁde-reduction step completely unlinked
A1 from A2. In the absence of furin digestion and/or
disulﬁde reduction, no peak was observed that corresponded
to the A2 fragment suggesting that both steps, performed
sequentially, are necessary for successful release of the αA2-
Stx2 and its ionization by MALDI. This sequential two-
step process follows the model proposed for eukaryotic
intracellular processing of α-Stx [9]. The higher MW αA1-
Stx2 fragment, although detected and identiﬁed by 1-D gel
electrophoresis and bottom-up proteomics, did not appear
to ionize eﬃciently by MALDI as an intact protein.
Top-down proteomics utilizing MALDI-TOF-TOF-
MS/MS and PSD is a rapid technique for identifying
high copy proteins expressed under standard culturing
conditions or highly expressed proteins that have been
induced to express under speciﬁc culturing conditions.
Identiﬁcation of such proteins can assist in the identiﬁcation
or characterization of bacteria and their potential for
causing severe illness due to the virulence factors that they
can express, for example, protein toxins.
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